Studies of Disorders With Increased Susceptibility to Fungal Infections

New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia

This study is designed to collect respiratory secretion specimens and blood samples to facilitate studies of human Pneumocystis infection and disease, to detect genes associated with drug resistance, and to assess strain variation.

Contact Information

Debra Reda, R.N. (301)496-9320
dreda@nih.gov

Joseph A Kovacs, M.D. (301) 496-9907
jkovacs@mail.nih.gov

Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov   

Laboratory of Infectious Diseases

Established in 1942, the NIAID Laboratory of Infectious Diseases (LID) has a long history of discovering new agents of viral diseases and developing innovative vaccines and treatments such as FluMist, a nasal spray influenza vaccine; Synagis, a preventative treatment for respiratory syncytial virus; and Havrix, a hepatitis A vaccine licensed by GlaxoSmithKline.

Clinical Trials Sponsored by the Laboratory of Infectious Diseases Clinic

The clinical trials and studies conducted by the Laboratory of Infectious Diseases Clinical Research Program change frequently, but you can see a list of all current clinical trials and studies being conducted by the Laboratory of Infectious Diseases Clinic on our Find a Clinical Trial page.

View Trials

The LID Clinical Studies Unit (LID CSU) seeks to perform translational research studies to answer fundamental questions regarding human influenza and other emerging viral infections to inform and impact future vaccine and therapeutic design, while also making an effort to assist in evaluation of novel products that may impact human health.

In recent years, the LID CSU has initiated efforts to perform uncommon and difficult, but necessary clinical studies to evaluate novel vaccines and therapeutics particularly universal influenza vaccines in the human challenge model and extremely novel universal vaccines for vector borne disease like Dengue, Zika, and Leishmaniasis.

Tour the Special Clinical Studies Unit

What is it Like to Participate?

Photo of Sara Jones

To me, science is better than magic. Through scientific research, we gain the ability to prevent or cure disease.

– Sara Jones

Contact Information

For questions about participating in clinical studies, contact:
Office of Patient Recruitment
Toll Free: 1-800-411-1222
TTY: 1-866-411-1010
Se habla español. Email: prpl@mail.cc.nih.gov

NIAID Primary Immune Deficiency Clinic

The NIAID Primary Immune Deficiency (PID) Clinic is located at the National Institutes of Health (NIH) Clinical Center and is dedicated to research on the more than 200 forms of primary immune deficiency diseases affecting approximately 500,000 people in the United States.

Clinical Trials Sponsored by the Primary Immune Deficiency Clinic

The clinical trials and studies conducted by the Primary Immune Deficiency Clinic change frequently, but you can see a list of all current clinical trials and studies being conducted by the Primary Immune Deficiency Clinic on our Find a Clinical Trial page.

View Trials

The clinic accepts patients who are at least 2 years old who have a known or suspected primary immune deficiency disease.

Before Your Visit

If you are interested in coming to the PID Clinic, discuss this option with your personal physician or specialist.

You must be referred to the PID Clinic by your doctor. Your doctor will need to send the PID Clinic staff the following information:

  • A summary letter describing your condition and current health status
  • A list of treatments and medicines you have taken
  • Copies of your complete medical records

Send the requested information and records by FedEx to:

National Institutes of Health
10 Center Drive
Building 10, Room 12C-103
Bethesda, MD 20892-1899
Attn: Carla Williams, RN
Phone: 301–496–4000

Our clinicians will notify your doctor and you of their decision by mail in about 6 to 8 weeks. If our clinicians determine that you would benefit from coming to the PID Clinic, you and your family will then be invited. Our clinical staff will send you a copy of the NIH Patient Handbook and a copy of the NIH Screening Consent prior to your visit to NIH.

Expenses

Your visit to the clinic is free, so there is no need to worry if your insurance will cover your visit. However, your initial travel expenses will not be covered.

For those arriving from outside the Washington, DC, metro area, some overnight housing is available on the NIH campus at the Children’s Inn. There are also many hotels and motels convenient to public transportation in the area.

During Your Visit

Plan to stay for at least one full day (approximately eight hours) of testing and evaluation. Some diagnostic tests take two days to complete, so you may need to return to the clinic for a half-day follow-up visit.

During your visit, you can expect the following:

  • Initial discussion with an NIAID clinician (Day 1)
  • Physical examination (Day 1)
  • Diagnostic tests, including blood work, CT scan, or MRI, if needed (Day 1 to 2)
  • Wrap-up session to review your test results, treatment recommendations, and diagnosis (Day 1 or 2)

Genome Sequencing

Any patient of the PID clinic is eligible to receive genome sequencing and associated services through the NIAID Centralized Sequencing Program. Patients interested in participating in the sequencing process can visit the NIAID Centralized Sequencing Program page for eligibility criteria and contact information.

Resources

Of Special Interest to Parents (NIH Clinical Center)

For Parents and Children (NIH)

Services Available at NIH

The NIH Clinical Center provides many services to its visitors, including counseling, a business center, and recreation. For details, visit the NIH Clinical Center Patient Services website.

Follow-up Care

Our staff is committed to helping you better manage your disease.

After your exam at the clinic is complete, you may be offered the opportunity to participate in ongoing clinical trials at NIAID. Only our clinicians can determine if you are eligible to participate.

Alternatively, you may be informed of primary immune deficiency diseases studies for which you may be eligible at clinical centers outside of NIAID.

Read More About the Research

Learn more about NIAID's research on primary immune deficiency diseases.

What is it Like to Participate?

Photo of Tony R. Lee

The best part of participating in the trial was seeing the staff during each visit: they were so upbeat, kind, and thankful. I felt as though I was part of a team that would change the world—and I know it will.

– Tony Lee

Contact Information

National Institutes of Health
10 Center Drive
Building 10, Room 12C-103
Bethesda, MD 20892-1899
Attn: Carla Williams, RN
Phone: 301–496–4000

Vaccine Research Center Clinical Studies

The Vaccine Research Center evaluates candidate vaccines and monoclonal antibodies targeting HIV, influenza, Ebola, and other emerging infections.

Clinical Trials Sponsored by the Vaccine Research Center

The clinical trials and studies conducted by the Vaccine Research Center change frequently, but you can see a list of all current clinical trials and studies being conducted by VRC on our Find a Clinical Trial page.

View Trials

The Vaccine Research Center is looking for adults 18 years of age and older to participate in trials evaluating vaccine and monoclonal antibodies

Why Volunteer?

  • Help researchers develop potentially lifesaving vaccines
  • Contribute to the advancement of medicine
  • Provide researchers with important scientific information in a safe and confidential environment
  • Receive financial compensation for your time

How It Works

  • An independent committee reviews all VRC studies for safety, ethics, and need before approving them for volunteer participation.
  • When you contact the VRC, you will be asked a few questions about your health.
  • If you meet certain criteria, a screening visit is scheduled in which you will undergo a blood draw and physical examination to determine your eligibility for a vaccine study.
  • You will receive a consent form that explains the study in detail and in non-technical language.
  • By signing the consent form, you are indicating that you understand the study and that you volunteer to participate. As a volunteer, you are free to withdraw from the study at any time.
  • All volunteers are compensated for their participation.

Once you agree to participate, we will follow the steps below.

Informed Consent

  • You will have an initial interview.
  • We will tell you about the study in detail.
  • We will answer any questions you have to make sure that you understand everything involved with participating in our trial.
  • You will read and sign a consent form for the study.

Eligibility Screening

  • We will ask you to complete a health questionnaire.
  • You will receive a clinical exam that includes blood tests and a physical exam.

Vaccination

  • Over the period of a few weeks or months (depending on the trial), you will receive a vaccination or a series of vaccinations.
  • You will be asked to keep a record of any physical reaction you have to the vaccine.
  • We will monitor the effects of the vaccine through periodic blood tests.
  • You will also receive physical examinations while you are participating in the trial.

Volunteer for a Clinical Study

If you are interested in volunteering to participate in a clinical study, please call us at 866-833-LIFE (5433) or email us at vaccines@nih.gov. We will send you information about our clinical studies and follow up with you to answer any questions.

Or fill out the volunteer information form and we will match you with studies and contact you.

Volunteer Form

Read More About the Research

Learn more about the work being done at NIAID’s Vaccine Research Center.

What is it Like to Participate?

Photo of  Peter Hubbard

Based on my personal experiences, I encourage people to look into the clinical trials at the VRC. You really cannot ask for nicer or more dedicated and knowledgeable staff than those at the VRC, and they appreciate all of their volunteers. Give it a shot and be a part of something truly important!

– Peter Hubbard

Contact Information

For more information or to volunteer for a vaccine research study

HIV and Emerging Infectious Diseases

NIAID and the National Institutes of Health (NIH) Warren G. Magnuson Clinical Center conduct clinical research on HIV, chronic viral hepatitis (hepatitis B and C), emerging infectious diseases, and other immunological disorders.

This joint research program is part of the NIH, the world's largest medical research institution, which is operated by the federal government.

Clinical Trials Sponsored by the HIV and Emerging Infectious Diseases Clinic

The clinical trials and studies conducted by the HIV and Emerging Infectious Diseases Program change frequently, but you can see a list of all current clinical trials and studies being conducted by the HIV and Emerging Infectious Diseases Clinic on our Find a Clinical Trial page.

View Trials

Some of the research studies at the NIH Clinical Center involve promising new treatments that may directly benefit patients.

What Is a Clinical Trial?

A clinical trial (also clinical research) is a research study in which people participate as volunteers.

A research study is a scientific investigation to achieve a complete understanding of a topic.

Carefully conducted clinical trials are the fastest and safest way to find

  • Treatments and medications that work in people
  • Ways to improve health

There are strict rules for clinical trials, which are monitored by

  • National Institutes of Health (NIH)
  • Food and Drug Administration

Basic Facts About the Clinical Trials

  • The trials are located in Bethesda, Maryland.
  • Some trials are only for people in the local area, but most permit people from anywhere in the United States to enroll.
  • Some travel costs may be covered.
  • There is no cost for study-related medical care or medicines.
  • People can be referred to a clinical trial by their personal physicians, or they can refer themselves.
  • There may be some compensation for time and inconvenience.

Why Participate?

Participants in clinical trials are

  • Seen by a team of expert doctors, nurses, technicians, and support staff
  • Often the first to receive promising new treatments before they become available in the community
  • Helping others with the same disease—both today and in the future

Participants in clinical trials can

  • Play a more active role in their own health care
  • Potentially gain access to new research treatments before they are widely available
  • Help others by contributing to greater medical knowledge

Read More About the Research

Learn more about the research conducted at NIAID to fight HIV and other emerging infectious diseases

What is it Like to Participate?

Photo of Kymone Freeman

I’ve realized that our only hope of truly curbing [the HIV/AIDS] pandemic is the discovery of a vaccine. This is why I fight.

– Kymone Freeman

Contact Information

Volunteer or get more information
Toll free: 1-800-411-1222
TTY: 1-866-411-1010
Se habla español

Emailprpl@mail.cc.nih.gov

Pathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis

Researchers want to study the immune systems of people with DCM or RCM, to learn more about the disease and the best ways to treat it. They also want to learn more about the types of people that get DCM or RCM and about the fungus that causes it.

Contact Information

Merertu Tesso (301)-402-7831
tessom@mail.nih.gov  

Steven M Holland, M.D. (301) -402-7684
sholland@mail.nih.gov

Apheresis and Specimen Collection Procedures to Obtain Plasma, Peripheral Blood Mononuclear Cells (PBMCs) and Other Specimens for Research Studies

This study collects specimens such as blood, urine, body fluids or secretions, skin swabs, or skin biopsies from volunteers for use in studies by the Vaccine Research Center. The samples are used for medical research, including the study of HIV, hepatitis, and other diseases; immune system responses, such as responses to vaccinations or infections; and for research on vaccine development.

Contact Information

VRC Clinic

301-451-8715

vaccines@nih.gov

VRC 900 Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older

Researchers need to collect specimens and images from individuals who have recently had a vaccination or recovered from an infection. These specimens and images are used to study different diseases and immune responses, and can be used to investigate ways to prevent or treat different medical conditions.

Contact Information

Pamela Costner, R.N.
301-451-8715
vaccines@nih.gov

Screening Volunteers for Clinical Trials

This is a screening study that is used to identify healthy volunteers who may be eligible to participate in other clinical trials at the Vaccine Research Center that evaluate investigational vaccines, monoclonal antibodies, and injection devices.

Contact Information

Ingelise Gordon, R.N, 301-451-8715

vaccines@nih.gov